News

This new arm will enroll HIV patients who have not yet begun highly active antiretroviral therapy (HAART) and who will receive IR103, Remune, or saline over 28 weeks.

In addition, the FDA has approved an update to the Enbrel (etanercept) label to include new radiographic data demonstrating that Enbrel continued to inhibit the progression of joint

Epratuzumab has been designated by the FDA as a fast track product for the potential treatment of patients with moderate and severe systemic lupus erythematosus (SLE), known as

The approval, for lamivudine tablets 150mg, is Ranbaxy’s first tentative approval under the expedited review process of the US President’s emergency plan for AIDS relief (PEPFAR) program. In

131I-TM-601 is a radiopharmaceutical containing a synthetic version of chlorotoxin, a substance derived from scorpion venom. Chlorotoxin, or TM-601, specifically seeks out and binds to a receptor expressed

The approval means Glumetza will be the first once-daily, extended-release formulation of metformin on the Canadian market. Biovail Pharmaceuticals Canada (BPC), the company’s sales and marketing division, will

This new approach to inhibiting blood vessel growth, or angiogenesis, delivers intraceptors that sequester VEGF (vascular endothelial growth factor), a protein needed to make blood vessels. In a

ITI is developing novel drugs for the treatment of schizophrenia, depression, Parkinson’s and Alzheimer’s disease and other disorders of the central nervous system (CNS). Under the terms of

The objective of the collaboration is to rapidly generate novel biocatalysts for use in manufacturing of Pfizer’s products, improving Pfizer’s R&D productivity while reducing the environmental footprint and